MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
More than 80 students and faculty from a dozen collaborating institutions became immersed at the intersection of computation and life sciences and forged new ties to MIT and each other.
Researchers survey a broadening landscape of studies showing what’s known, and what remains to be found, about the therapeutic potential of noninvasive sensory, electrical, or magnetic stimulation of gamma brain rhythms.
Professor Wit Busza, Instructor Karol Bacik, postdocs Cari Cesarotti and Chao Li, and Pablo Gaston Debenedetti SM ’81, PhD ’85 honored for contributions to physics.